纳斯达克 -- -- --

最近浏览

鼎信控股

NASDAQ:DXST 延时15分钟
  • 今开:--
    昨收:--
  • 今日区间:--
    52周区间:--
  • 成交量:--
    成交额:--
  • 市 值:--
    市盈率:--
  • 振幅:
    每股收益:
成交量

董事会

Ding Xin Sun
Mr. Ding Xin Sun is a Chairman at Decent Holding, Inc. Mr. Sun was previously employed as a Founder by Yantai Dingxin Environmental Ltd., a Founder by Yantai Sunshine Gymnastic Ltd., and a Founder by Yantai Tongqu Wanxiang Cultural Entertainment Ltd. He received his undergraduate degree from Ludong University.
Ding Yan Sun
Ms. Ding Yan Sun is on the Board of Directors at Decent Holding, Inc. Ms. Sun was previously employed as a Manager by Yantai Development Zone Xingshun Petroleum Co. Ltd.
Zi Jian Tong
Mr. Zi Jian Tong is an Independent Director at Decent Holding, Inc., an Independent Director at PS International Group Ltd., a Member at The Chartered Institute of Management Accountants and an Independent Director at Xinzi. He is on the Board of Directors at Decent Holding, Inc., PS International Group Ltd. and Xinzi. Mr. Tong was previously employed as a Partner by CNZF Management Co. Ltd., a Secretary & Director-Investor Relations by Beijing Yicai Hongye Management Consulting Co., Ltd., a Vice President-Finance by Rodobo International, Inc., and a Vice President by China Hand Fund I LLC. He received his undergraduate degree from Dalian Maritime University and an MBA from INSEEC Business School.
Tao Feng
Mr. Tao Feng is an Independent Director at Decent Holding, Inc., a Member at China National Democratic Construction Association and a Senior Partner at Capital Equity Legal Group. He is on the Board of Directors at Decent Holding, Inc. He received his undergraduate degree from Ningbo University and a graduate degree from Zhejiang University.
Chun Yu Chow
Chun Yu Chow currently works at Decent Holding, Inc., as Independent Director from 2025, Xinzi, as Iindependent Director, Lianhe Sowell International Group Ltd., as Independent Director from 2025, and Hang Feng Technology Innovation Co., Ltd., as Chief Financial Officer from 2025. Mr. Chow also formerly worked at ABVC BioPharma, Inc., as Chief Financial Officer & Accounting Officer from 2022 to 2024. Mr. Chow received his undergraduate degree from the University of California, Santa Barbara.